Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001021607 | SCV001183245 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000869137 | SCV001334516 | likely benign | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001519063 | SCV001727866 | benign | Tuberous sclerosis 2 | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001519063 | SCV002039404 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003035 | SCV004815220 | likely benign | Tuberous sclerosis syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing |